Once-Monthly Oral PrEP Option Appears Safe, Tolerable in Adults at Low Risk of HIV

(MedPage Today) — The investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to placebo, with dose-proportional pharmacokinetics, among adults with a low likelihood of HIV-1 exposure…

Source link : https://www.medpagetoday.com/meetingcoverage/ias/116568

Author :

Publish date : 2025-07-18 14:50:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Once-Monthly Oral PrEP Option Appears Safe, Tolerable in Adults at Low Risk of HIV

are hospital surgery wait times improving near you?

MedPod Today: Trans Healthcare Targeted; OTC Ivermectin; Low-Key BBB Provisions

Related Posts

FDA Advisors Give PTSD Drug Combination a Thumbs Down

What Are the Health Impacts of the $9 Billion Rescissions Package?

Trump’s Chronic Venous Insufficiency: What to Know About the Common Condition

Remove Boxed Warning on Hormone Therapy for Menopause, FDA Panel Says

Novel Guillain-Barre Mimic Emerges in Kids With Certain Gene Variants

Your chance of having a boy or girl may not be 50/50

FDA Advisors Give PTSD Drug Combination a Thumbs Down

What Are the Health Impacts of the $9 Billion Rescissions Package?

Trump’s Chronic Venous Insufficiency: What to Know About the Common Condition

Remove Boxed Warning on Hormone Therapy for Menopause, FDA Panel Says

Novel Guillain-Barre Mimic Emerges in Kids With Certain Gene Variants

Your chance of having a boy or girl may not be 50/50

Adults With HIV Report Greater Satisfaction After Switching to Long-Acting ART

A Physician’s Guide to What’s Next

Categories

Archives